Nisa Investment Advisors LLC Has $172,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Nisa Investment Advisors LLC cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 31.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,588 shares of the company’s stock after selling 1,174 shares during the quarter. Nisa Investment Advisors LLC’s holdings in HealthEquity were worth $172,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HQY. McGlone Suttner Wealth Management Inc. acquired a new position in shares of HealthEquity in the 4th quarter valued at about $29,000. Castleview Partners LLC acquired a new position in shares of HealthEquity in the 2nd quarter valued at about $39,000. Lazard Asset Management LLC lifted its stake in shares of HealthEquity by 117.9% in the 3rd quarter. Lazard Asset Management LLC now owns 549 shares of the company’s stock valued at $40,000 after purchasing an additional 297 shares during the period. DekaBank Deutsche Girozentrale acquired a new position in shares of HealthEquity in the 3rd quarter valued at about $41,000. Finally, Fifth Third Bancorp lifted its stake in shares of HealthEquity by 36.5% in the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after purchasing an additional 161 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a research note on Tuesday, April 2nd. Royal Bank of Canada boosted their price objective on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, March 20th. KeyCorp boosted their price objective on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, March 22nd. Bank of America boosted their target price on HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of HealthEquity in a research report on Friday, March 22nd. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.17.

HealthEquity Stock Performance

Shares of HQY opened at $80.89 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76. The stock has a 50 day moving average price of $81.08 and a two-hundred day moving average price of $74.26. The firm has a market capitalization of $6.94 billion, a P/E ratio of 126.39, a P/E/G ratio of 1.30 and a beta of 0.53. HealthEquity, Inc. has a 52 week low of $48.86 and a 52 week high of $84.49.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. The firm had revenue of $262.39 million during the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. Equities analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 2,499 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at approximately $3,999,680. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Jon Kessler sold 33,765 shares of the company’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the transaction, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 2,499 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $80.00, for a total value of $199,920.00. Following the completion of the transaction, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at $3,999,680. The disclosure for this sale can be found here. In the last ninety days, insiders sold 71,322 shares of company stock valued at $5,682,895. Corporate insiders own 2.70% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.